Doctors often use different methods to help people manage chronic pain. One common approach is prescribing opioid painkillers. These medicines can be very effective, but they also come with serious ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

Headaches and migraine, including mild tension headaches, are linked to an increased risk of suicide, according to new ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...